Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition (PLoS Biology (2019) 17:9 (e3000354) DOI: 10.1371/journal.pbio.3000354)

Lieselotte Vande Walle; Irma B. Stowe; Pavel Šácha; Bettina L. Lee; Dieter Demon; Amelie Fossoul; Filip van Hauwermeiren; Pedro H.V. Saavedra; Petr Šimon; Vladimír Šubr; Libor Kostka; Craig E. Stivala; Victoria C. Pham; Steven T. Staben; Sayumi Yamazoe; Jan Konvalinka; Nobuhiko Kayagaki; Mohamed Lamkanfi

ArticleOPEN ACCESS

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition (PLoS Biology (2019) 17:9 (e3000354) DOI: 10.1371/journal.pbio.3000354)

PLoS Biology

DOI: 10.1371/journal.pbio.3000529

7Citations

6Readers

Abstract

The tenth author’s name is spelled incorrectly. The correct name is: Vladimír Šubr.

Cite

CITATION STYLE

APA

Walle, L. V., Stowe, I. B., Šácha, P., Lee, B. L., Demon, D., Fossoul, A., … Lamkanfi, M. (2019). Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition (PLoS Biology (2019) 17:9 (e3000354) DOI: 10.1371/journal.pbio.3000354). PLoS Biology. Public Library of Science. https://doi.org/10.1371/journal.pbio.3000529

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition (PLoS Biology (2019) 17:9 (e3000354) DOI: 10.1371/journal.pbio.3000354)

Abstract

Cite

Register to see more suggestions